RT Journal Article
T1 SEA 2022 Standards for Global Control of Cardiovascular Risk.
T2 Estándares SEA 2022 para el control global del riesgo cardiovascular.
A1 Mostaza, Jose Maria
A1 Pintó, Xavier
A1 Armario, Pedro
A1 Masana, Luis
A1 Real, José T
A1 Valdivielso, Pedro
A1 Arrobas-Velilla, Teresa
A1 Baeza-Trinidad, Ramón
A1 Calmarza, Pilar
A1 Cebollada, Jesús
A1 Civera-Andrés, M
A1 Cuende Melero, J I
A1 Díaz-Díaz, J L
A1 Fernández Pardo, J
A1 Guijarro, C
A1 Jericó, C
A1 Laclaustra, M
A1 Lahoz, C
A1 López-Miranda, J
A1 Martínez-Hervás, S
A1 Muñiz-Grijalvo, O
A1 Páramo, J A
A1 Pascual, V
A1 Pedro-Botet, J
A1 Pérez-Martínez, P
A1 Plana, N
A1 Puzo, J
A1 Sánchez Chaparro, M Á
A1 Vila, L
K1 Arterial hypertension
K1 Atrial Fibrillation
K1 Cardiovascular prevention
K1 Diabetes
K1 Dislipemia
K1 Dyslipidaemia
K1 Fibrilación auricular
K1 Hipertensión arterial
K1 Prevención cardiovascular
K1 Smoking
K1 Tabaquismo
AB One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation.
YR 2022
FD 2022-01-25
LK http://hdl.handle.net/10668/22022
UL http://hdl.handle.net/10668/22022
LA en
LA es
DS RISalud
RD Apr 18, 2025